[Skip to Content]

Upstate Active Clinical Trials

Study Title:

ADC-042-PRAZ: Prazosin for Disruptive Agitation in Alzheimer’s Disease (AD) (PEACE-AD)

What is the purpose of the study?

The purpose of this research is to see if a drug called prazosin can help make agitation symptoms such as irritability, anger outbursts, and pacing better for patients with Alzheimer’s disease.

Upstate Institutional Review Board (IRB) Number:

1689413

Study/Protocol ID:

ADC-042-PRAZ (PEACE-AD)

Study Phase:

Phase 2b

Patient Age Group:

Adults

Principal Investigator:

Sharon A Brangman

What is involved if I participate?

  • How long is the study?
    16 weeks
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No
  • What tests and procedures are involved?
    Blood tests, ECG, vitals, behavioral assessment, activities of daily living assessment

Where will the study take place?

Institute for Human Performance. Remote visits also available.

Other Information:

Study partner required

ClinicalTrials.Gov ID:

NCT03710642

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Megan Schuler
Phone: 315-464-9597
Email: schulerm@upstate.edu

Return to Previous Page || Search Again

Top